Edward Ayoub

10PUBLICATIONS
58CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersHaematological tumoursMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Apr 14, 2026
Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati, Hagop M Kantarjian, Edward Ayoub

|Jul 03, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.

Bing Z Carter, Po Yee Mak, Edward Ayoub

|Mar 04, 2025
BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway.

Amnon Peled, Michal Abraham, Hanna Wald

|Mar 08, 2024
Correction: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.

Hiroki Akiyama, Ran Zhao, Lauren B Ostermann

|Dec 26, 2023
Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.

Hiroki Akiyama, Ran Zhao, Lauren B Ostermann

Pageof 2

Frequent Collaborators

7 joint publications

Michael Andreeff

5 joint publications

Lauren B Ostermann

4 joint publications

Bing Z Carter

3 joint publications

Vivian R Ruvolo